TG Therapeutics, Inc. (TGTX)

USD 31.07

(-7.46%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 329.58 Million 193.57 Million 379.62 Million 625.64 Million 163.01 Million 83.61 Million
Total Current Assets 317.94 Million 168.27 Million 330.96 Million 611.74 Million 149.15 Million 79.03 Million
Cash And Short Term Investments 217.5 Million 174.08 Million 350.29 Million 605.42 Million 140.43 Million 68.8 Million
Cash and Cash Equivalents 92.93 Million 102.3 Million 298.88 Million 553.43 Million 112.63 Million 41.95 Million
Short Term Investments 124.57 Million 59.37 Million 15.87 Million 51.98 Million 27.79 Million 26.84 Million
Net Receivables 51.09 Million - 1.38 Million - - 95 Thousand
Inventory 39.82 Million - -23.6 Million - - 9.69 Million
Other Current Assets 9.51 Million 6.59 Million 2.88 Million 1.08 Million 611 Thousand 439 Thousand
Total Non-Current Assets 11.64 Million 25.29 Million 48.66 Million 13.9 Million 13.86 Million 4.58 Million
Net PPE 8.14 Million 10.82 Million 11.06 Million 11.84 Million 11.81 Million 2.54 Million
Good Will And Intangible Assets 799 Thousand 799 Thousand 799 Thousand 799 Thousand 799 Thousand 799 Thousand
Good Will 799 Thousand 799 Thousand 799 Thousand 799 Thousand 799 Thousand 799 Thousand
Intangible Assets - - - - - -
Long-Term Investments 1.28 Million 12.4 Million 35.53 Million 1.25 Million 1.25 Million 1.24 Million
Tax Assets - - - -1.25 Million -1.25 Million -1.24 Million
Other Non Current Assets 1.41 Million 1.27 Million 1.26 Million 1.25 Million 1.25 Million 1.24 Million
Other Assets - - - - - -
Total Liabilities 169.08 Million 134.98 Million 142.47 Million 106.29 Million 124.39 Million 59.58 Million
Total Current Liabilities 53.72 Million 53.2 Million 65.38 Million 87.55 Million 84.44 Million 38.85 Million
Account Payables 38.47 Million 42.01 Million -457 Thousand 37.01 Million 30.04 Million 36.37 Million
Tax Payables - - - - - -
Short Term Debt 1.44 Million 1.58 Million 2.41 Million 23.84 Million 1.61 Million 67 Thousand
Deferred Revenue 300 Thousand 305 Thousand 457 Thousand 152 Thousand 47.35 Million 152 Thousand
Other Current Liabilities 13.5 Million 9.29 Million 62.97 Million 26.54 Million 5.44 Million 2.25 Million
Total Non Current Liabilities 115.36 Million 81.78 Million 77.09 Million 18.73 Million 39.95 Million 20.72 Million
Long-Term Debt 100.11 Million 81.47 Million 76.63 Million 18.12 Million 39.18 Million -
Deferred Revenue Non Current 6.01 Million 305 Thousand 457 Thousand 610 Thousand 762 Thousand 914 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 106.13 Million 71.44 Million 67.24 Million -7.71 Million -28.97 Million 19.81 Million
Other Liabilities - - - - - -
Total Equity 160.5 Million -1.52 Billion -1.32 Billion 519.35 Million -701.21 Million 24.03 Million
Stock Holders Equity 160.5 Million -1.52 Billion -1.32 Billion 519.35 Million -701.21 Million 24.03 Million
Common Stock 151 Thousand 146 Thousand 143 Thousand 141 Thousand 109 Thousand 84 Thousand
Retained Earnings -1.51 Billion -1.52 Billion -1.32 Billion -980.59 Million -701.21 Million -528.34 Million
Accumulated other comprehensive income - - - - - -
Common Stock Equity 160.5 Million -1.52 Billion -1.32 Billion 519.35 Million -701.21 Million 24.03 Million
Capital Lease Obligation 9.23 Million 11.92 Million 11.28 Million 12.08 Million 11.83 Million -
Total Investments 125.86 Million 71.77 Million 51.4 Million 51.98 Million 27.79 Million 26.84 Million
Total Debt 110.79 Million 83.06 Million 79.04 Million 41.97 Million 40.8 Million 67 Thousand
Net Debt 17.86 Million -19.24 Million -219.84 Million -511.46 Million -71.83 Million -41.89 Million

Balance Sheet Charts